Carbon-based ruthenium nanomaterial-based electroanalytical sensors for the detection of anticancer drug Idarubicin

Ultrasensitive Functionalized Polymeric-Nanometal Oxide Sensors for Potentiometric Determination of Ranitidine Hydrochloride

Two metal oxide nanoparticles, magnesium oxide nanoparticles (MgONPs) and aluminum oxide nanoparticles (Al₂O₃NPs), were synthesized from green sources, Salvia officials and Cuminum cyminum seed extract, respectively. These nanoparticles were used for construction of potentiometric enhancement sensors employed for the estimation of ranitidine hydrochloride (RNT) in authentic powder and commercial products. The electroactive substance ranitidine-phosphotungstate (RNT-PT) was formed by combining RNT with phosphotungstic acid (PTA) in the presence of plasticizing material o-nitrophenyloctyl ether (o-NPOE). The outcomes showed that the enhanced MgO and Al₂O₃ nanosensors behaved linearly across the concentration ranges 1.0 × 10^-9-1.0 × 10^-2 and 1.0 × 10^-10-1.0 × 10^-2 mol L^-1, respectively. However, the conventional sensor (RNT-PT) displayed a linearity over 1.0 × 10^-6-1.0 × 10^-2 mol L^-1. Least square equations were calculated as E_mV = (54.1 ± 0.5) log (RNT) + 762.33, E_mV = (58.6 ± 0.2) log (RNT) + 696.48, and E_mV = (52.2 ± 0.7) log (RNT) + 756.76 for enriched nanometal oxides modified and conventional sensors, respectively. The correlation coefficients of regression equations were 0.9997, 0.9995, and 0.9992 for the above suggested sensors, respectively. The recorded results showed excellent sensitivity and selectivity of the modified nanometal oxide sensors for the quantification of the analyzed drug in its authentic samples and commercial products.

A reusable and sensitive electrochemical sensor for determination of idarubicin in environmental and biological samples based on NiFe2O4 nanospheres anchored N-doped graphene quantum dots composite; an electrochemical and molecular docking investigation

An ultrasensitive and selective voltammetric sensor with ultra-trace level detection limit is introduced for idarubicin (IDA) determination in real samples. The as-synthesized nanocomposite was characterized by several techniques, including Fourier transform infrared spectroscopy (FT-IR), X-ray diffraction (XRD), Raman spectroscopy, Energy-dispersive X-ray spectroscopy (EDX), and Field emission scanning electron microscopy (FE-SEM). The electrocatalytic performance of the developed electrode was observed by cyclic voltammetry (CV), differential pulse voltammetry (DPV), electrochemical impedance spectroscopy (EIS), and chronoamperometry. The limit of detection (LOD) of the developed sensor for idarubicin is 1.0 nM, and the response is found to be in the dynamic concentration range of 0.01-1.9 μmol/L in a Britton-Robinson buffer (B-R, pH = 6.0). Moreover, the fabricated electrode illustrated high selectivity with good repeatability and reproducibility for diagnosing idarubicin as an anthracycline antileukemic drug. Furthermore, to evaluate the validity of the recommended method, three real samples, including human plasma, urine, and water samples, were analyzed with satisfactory recovery and compared with high-performance liquid chromatography (HPLC). The minor groove-binding mode of interaction was also supported by docking simulation studies, emphasizing that IDA can bind to ds-DNA preferably and confirmed experimental results. The reduced assay time and the possibility of measuring a single sample with another anticancer drug without any interference are significant advantages compared to the HPLC. The developed and validated sensor could be a valuable point-of-care diagnostic tool for IDA quantification in patients.

Electrochemistry as a Powerful Tool for Investigations of Antineoplastic Agents: A Comprehensive Review

Cancer is most frequently treated with antineoplastic agents (ANAs) that are hazardous to patients undergoing chemotherapy and the healthcare workers who handle ANAs in the course of their duties. All aspects related to hazardous oncological drugs illustrate that the monitoring of ANAs is essential to minimize the risks associated with these drugs. Among all analytical techniques used to test ANAs, electrochemistry holds an important position. This review, for the first time, comprehensively describes the progress done in electrochemistry of ANAs by means of a variety of bare or modified (bio)sensors over the last four decades (in the period of 1982-2021). Attention is paid not only to the development of electrochemical sensing protocols of ANAs in various biological, environmental, and pharmaceutical matrices but also to achievements of electrochemical techniques in the examination of the interactions of ANAs with deoxyribonucleic acid (DNA), carcinogenic cells, biomimetic membranes, peptides, and enzymes. Other aspects, including the enantiopurity studies, differentiation between single-stranded and double-stranded DNA without using any label or tag, studies on ANAs degradation, and their pharmacokinetics, by means of electrochemical techniques are also commented. Finally, concluding remarks that underline the existence of a significant niche for the basic electrochemical research that should be filled in the future are presented.

Review of the Design of Ruthenium-Based Nanomaterials and Their Sensing Applications in Electrochemistry

In this review, ruthenium nanoparticles (Ru NPs)-based functional nanomaterials have attractive electrocatalytic characteristics and they offer considerable potential in a number of fields. Ru-based binary or multimetallic NPs are widely utilized for electrode modification because of their unique electrocatalytic properties, enhanced surface-area-to-volume ratio, and synergistic effect between two metals provides as an effective improved electrode sensor. This perspective review suggests the current research and development of Ru-based nanomaterials as a platform for electrochemical (EC) sensing of harmful substances, biomolecules, insecticides, pharmaceuticals, and environmental pollutants. The advantages and limitations of mono-, bi-, and multimetallic Ru-based nanocomposites for EC sensors are discussed. Besides, the relevant EC properties and analyte sensing approaches are also presented. On the basis of these insights, we highlighted recent results for synthesizing techniques and EC environmental pollutant sensors from the perspectives of diverse supports, including graphene, carbon nanotubes, silica, semiconductors, metal sulfides, and polymers. Finally, this work overviews the modern improvements in the utilization of Ru-based nanocomposites on the basis for electroanalytical sensors as well as suggestions for the field's future development.

Carbon nanomaterials and its applications in pharmaceuticals: A brief review

Nanotechnology for the past decade has made tremendous improvement and diverse applications in various sector. Among the nanomaterials synthesized, carbon allotropes are advantageous due to its easy functionalization, conductivity, surface area and electrical activity. Hence, they are termed as "Wonder materials". Allotropes such as carbon nanotubes, graphene, graphene oxide, fullerens, and carbon dots has paved its importance in the pharmaceuticals. They are coated in the biomedical devices, applied in the therapeutics and diagnosis. These are also used in the treatment of cancer and they possess anti-microbial and antiviral activity. Carbon nanomaterials possess several applications from biosensors to remediation of pollutants. Detection of hazardous compounds in food, pharmaceutical products, gene and drug delivery. They are also used in tissue regeneration and gene therapy. Application of carbon allotropes in the current scenario provides a wide scope in future with improvisations in building electrochemical biosensors. Its selectivity, sensitivity and cost-effectiveness prove it to be better alternative compared to other nanomaterials. The review focuses on the carbon allotropes used in pharmaceuticals, biosensors, pollutants detection and treatment were discussed in detail.

A novel biosensor for detecting vitamin C in milk powder based on Hg2+-mediated DNA structural changes

Background:

Detection of Vitamin C (Vc) is very important to protect human health. A lot of methods have been developed for the detection of Vc. However, many methods require complex material preparation and skilled operators. Thus, a simple, label-free biosensor is still urgently needed.

Methods:

In this work, N-methylmesoporphyrin IX (NMM)/G-quadruplex pair was used as a label-free signal reporter. Without Vc, the G-quadruplex DNA and its incomplete complementary chain could form duplex structure by T-Hg(II)-T mismatch. In this case, the G-quadruplex structure could not be formed. When Vc was added, the Hg2+ was reduced to Hg(0). Then, the G-quadruplex DNA became free and formed G-quadruplex structure to emit fluorescence signal.

Results:

Under optimal conditions, this biosensor showed a good linear response in the range of 0.2 - 4.0 μM and a low limit of detection (19.9 nM). This biosensor also had good selectivity towards Vc. Meanwhile, the satisfactory recovery rates (93.2%-102.8%) suggested that this biosensor had attractive potential for measuring Vc in real samples.

Conclusion:

In this work, a simple label-free fluorescent biosensor for the detection of Vc based on Hg2+-mediated DNA structural changes had been developed. The whole experiment was simple and all reagents were commercialized. The label-free detection was realized by NMM/G-quadruplex as a signal reporter. This biosensor was very sensitive with a low limit of detection. And it had a potential practical application for the Vc detection in milk powder.

A green and sensitive guanine-based DNA biosensor for idarubicin anticancer monitoring in biological samples: A simple and fast strategy for control of health quality in chemotherapy procedure confirmed by docking investigation

Drug efficiency can be considerably boosted while adverse effects can be reduced by precisely monitoring the concentration of anti-cancer drugs. Thus, one of the most important parameters for human health is the monitoring and detection of anticancer drugs during chemotherapy treatment. Herein, a glassy carbon electrode (GCE) was modified by Pt- and Pd-incorporated ZnO nanoparticles-decorated single-wall carbon nanotubes (Pt-Pd-ZnO/SWCNTs) nanocomposites, and ds-DNA (Calf Thymus) that was a biological recognition element, and it was aimed to be utilized as an ultrasensitive and effective electroanalytical biosensor for idarubicin (IDR) monitoring. Various physicochemical characterization techniques including transmission electron microscopy (TEM), field-emission scanning electron microscopy (FE-SEM) with energy-dispersive X-ray spectroscopy (EDS) were used to investigate the morphology and structure of the Pt-Pd-ZnO/SWCNTs nanocomposite, which was produced via straightforward chemical precipitation combined with the one-pot method. The layer-by-layer modification technique was implemented to fabricate the ds-DNA/Pt-Pd-ZnO/SWCNTs/GCE to be further utilized as a voltammetric sensor for sensitive monitoring of idarubicin in biological fluids and pharmaceutical substances. The electroanalytical method implemented to detect idarubicin was based to detect the ds-DNA's guanine base signal on the surface of the modified electrode in the absence and presence of the anticancer drug. The results explicated that the developed biosensor performed well in determining idarubicin in concentrations ranging from 1.0 nM to 65 μM, with a detection limit of 0.8 nM. The idarubicin detection ability of the modified electrode in real samples was evaluated, and the recovery data was acquired in the range of 98.0% and 104.75%. In the final step, the preferential intercalative binding mode of idarubicin drug with ds-DNA was approved by molecular docking study. This study paves the way for engineering highly sensitive DNA biosensors to be employed in the monitoring of anticancer drugs by combining the benefits of nanocomposites and valuable information of a molecular docking study.

Metal-Organic Framework-Based Composites for the Detection and Monitoring of Pharmaceutical Compounds in Biological and Environmental Matrices

The production of synthetic drugs is considered a huge milestone in the healthcare sector, transforming the overall health, aging, and lifestyle of the general population. Due to the surge in production and consumption, pharmaceutical drugs have emerged as potential environmental pollutants that are toxic with low biodegradability. Traditional chromatographic techniques in practice are time-consuming and expensive, despite good precision. Alternatively, electroanalytical techniques are recently identified to be selective, rapid, sensitive, and easier for drug detection. Metal-organic frameworks (MOFs) are known for their intrinsic porous nature, high surface area, and diversity in structural design that provides credible drug-sensing capacities. Long-term reusability and maintaining chemo-structural integrity are major challenges that are countered by ligand-metal combinations, optimization of synthetic conditions, functionalization, and direct MOFs growth over the electrode surface. Moreover, chemical instability and lower conductivities limited the mass commercialization of MOF-based materials in the fields of biosensing, imaging, drug release, therapeutics, and clinical diagnostics. This review is dedicated to analyzing the various combinations of MOFs used for electrochemical detection of pharmaceutical drugs, comprising antibiotics, analgesics, anticancer, antituberculosis, and veterinary drugs. Furthermore, the relationship between the composition, morphology and structural properties of MOFs with their detection capabilities for each drug species is elucidated.